3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
COVID-19
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Spondylitis, Ankylosing
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hypogonadism
1
Head and Neck Neoplasms
1
HIV Infections
1
Death
1
Crohn Disease
1
Colitis, Ulcerative
1
Interventions
Oxaliplatin
7
Fluorouracil
7
Paclitaxel
5
Leucovorin
5
pembrolizumab
4
Trastuzumab
4
Radiation
4
Capecitabine
4
tislelizumab
3
Taxes
3
Specimen Handling
3
Nivolumab
3
Carboplatin
3
ulixertinib
2
trastuzumab biosimilar HLX02
2
patritumab deruxtecan
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pemetrexed
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Irinotecan
2
Exercise
2
Docetaxel
2
Cisplatin
2
CT-P6
2
zolbetuximab
1
zimberelimab
1
zanidatamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Practice Guidelines as Topic
×
30 days
×
Clear all
No trials found.